OCGN Ocugen, Inc. Company Short-Term Debts

Ocugen - graphic logo of issuer OCGN

Ocugen, Inc. (OCGN) specializes in the development of innovative biologics and vaccines. This price chart on the GURU.Markets platform captures the 0.00 metric, reflecting the business's financial standing. Production stability is maintained by diversifying raw material supplies between US and foreign counterparties. However, investors should consider the challenges regarding government drug approvals and the reliance on external loans.

ocugen.com (OCGN) - Company Short-Term Debts from 07/04/2022 to 11/01/2026

Analytical breakdowns and data insights for company Ocugen Pharma (OCGN)

- current quotes and average value forecast:
Price Chart Ocugen|OCGN - Average Forecast Price
- market capitalization data:
Market Capitalization Ocugen, Inc.|OCGN - Real Price to Acquire Entire Company
- business book valuation details:
Accounting Value per Share Ocugen|OCGN - Book Capitalization|Market Capitalization to Book Value Ratio ocugen.com|OCGN - Company Balance Sheet Assets
- debt and liquidity data:
Total Debt to Capital Ocugen, Inc.|OCGN - Long-Term Liabilities to Capital|Short-Term Debt to Equity Ocugen, Inc.|OCGN - Company Aggregate Debt|Debt to Book Value Ocugen, Inc.|OCGN - Company Long-Term Loans and Borrowings|Company Short-Term Debts Ocugen|Quick Liquidity ocugen.com
- earnings and valuation multiples indicators:
OCGN - Company Profit
Fundamental valuation:Ocugen - OCGN
Manufactured products of Ocugen, Inc.

For Ocugen, Inc. (OCGN), a developer of gene therapies, the current liability ratio reflects short-term obligations maturing within one year. This metric aggregates all current loans and borrowings, measuring the real-time financial burden on capital. A downward trend on the chart minimizes default risks during prolonged research phases. Given the dependence on FDA decisions, this indicator demonstrates the company's ability to fund R&D without critical debt pressure.

Competing companies

TEM - Company Short-Term Debt|Short-Term Debt Qiagen NV|IONS: Company Short-Term Debts|Company Current Liabilities Repligen Inc.|Company Current Liabilities RNA|Company Short-Term Debts crisprtx.com|Company Short-Term Debts WGS|Ultragenyx Pharmaceutical Inc. (RARE) - Short-Term Indebtedness|Company Short-Term Debts BEAM (Beam Therapeutics Corp)|Sarepta Corp (SRPT) - Short-Term Debt|TWST - Company Short-Term Debt|TXG (10xgenomics.com) - Company Short-Term Indebtedness|NTLA (Intellia Therapeutics, Inc.) - Company Current Liabilities|Stoke Therapeutics Inc - Company Short-Term Loans and Borrowings|BLFS (BioLife Corp) - Company Short-Term Debts|Wave Pharma (WVE) - Short-Term Debt Volume|Company Short-Term Debt Maze Therapeutics Inc (MAZE)|sionnatx.com - Company Short-Term Indebtedness|Company Short-Term Debts PRME (Prime Medicine)|TSHA - Company Current Liabilities|QURE: Company Current Liabilities|Short-Term Debt Volume MeiraGTx Corp MGTX|REGENXBIO Inc. (RGNX) - Company Short-Term Debt|Short-Term Debt solidbio.com (SLDB)|PACB (PacBio) - Company Short-Term Debts|Company Current Liabilities Benitec Biopharma Inc (BNTC)|Company Short-Term Debts DSGN|Rocket Corp (RCKT) - Short-Term Indebtedness|Company Short-Term Debt 4D Molecular Therapeutics FDMT|LXEO: Company Short-Term Indebtedness|Korro Bio, Inc - Company Short-Term Debts|EDIT (Editas Medicine Inc) - Company Short-Term Indebtedness|Silence Therapeutics Inc. (SLN) - Company Short-Term Debt|Company Short-Term Indebtedness PRQR|CDXS (Codexis Inc) - Company Short-Term Debts|Company Short-Term Debts sangamo.com|Company Short-Term Debt Nautilus Biotechnology (NAUT)|MGX - Short-Term Debt|Company Short-Term Debts DTIL (Precision BioSciences)|GBIO - Company Current Liabilities|BOLD: Company Current Liabilities|XCUR - Company Short-Term Debts|IMNN: Company Short-Term Debts|Short-Term Indebtedness Phio Pharmaceuticals Corp. PHIO|MBIO (Mustang Bio Inc) - Company Short-Term Debts|Short-Term Debt TransCode RNAZ|Company Short-Term Debt Bionano Genomics, Inc. (BNGO)|adnas.com - Company Short-Term Indebtedness|bluebird bio - Company Current Liabilities|Company Short-Term Loans and Borrowings IPA|Omega - Company Short-Term Debts|Short-Term Debt Volume Singular Genomics Corp OMIC|Regulus Therapeutics (RGLS) - Company Short-Term Debt|Company Short-Term Indebtedness SYRS|TBIO (Telesis Bio) - Company Short-Term Debts|Company Current Liabilities TRACON Pharmaceuticals Inc. (TCON)|Company Current Liabilities UBX (Unity Bio)